Stocksigma LogoStocksigma Logo

Windlas Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results

Windlas Biotech Limited's Board of Directors is scheduled to meet on 5th Nov'26 to consider and approve the un-audited standalone financial results for the

Windlas Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results

Windlas Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Windlas Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results Windlas Biotech Limited's Board of Directors is scheduled to meet on 5th Nov'26 to consider and approve the un-audited standalone financial results for the quarter and half year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for designated persons, closed since 1st Oct'26, will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Windlas Biotech Ltd

All Windlas Biotech Ltd announcements